Beigene Ltd
NASDAQ:ONC

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
NASDAQ:ONC
Watchlist
Price: 313.36 USD -0.85% Market Closed
Market Cap: 436.8B USD

EV/EBITDA
Enterprise Value to EBITDA

227.3
Current
-12.3
Median
6.3
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
227.3
=
Enterprise Value
231.9B CNY
/
EBITDA
1B CNY
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
KY
Beigene Ltd
NASDAQ:ONC
Average EV/EBITDA: 61
227.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 560.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
11%
1.6
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.1
N/A N/A
NL
argenx SE
XBRU:ARGX
58.8
807%
0.1

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
hidden
2-Years Forward
EV/EBITDA
hidden
3-Years Forward
EV/EBITDA
hidden